Molecular targeted therapies for cancer: Sorafenib monotherapy and its combination with other therapies (Review)

Author：

ISSN： 1021-335X

Source： Oncology Reports, Vol.27, Iss.5, 2012-01, pp. : 1303-1311

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeted molecular therapies for ovarian cancer: an update and future perspectives (Review)

Oncology Reports, Vol. 28, Iss. 2, 2012-01 ,pp. : 395-408

Spandidos Publications

Access to resources Recommend Favorite

Cancer treatment: the combination of vaccination with other therapies

By Andersen Mads Sørensen Rikke Schrama David Svane Inge Becker Jürgen thor Straten Per

Cancer Immunology, Immunotherapy, Vol. 57, Iss. 11, 2008-11 ,pp. : 1735-1743

Springer Publishing Company

Access to resources Recommend Favorite

Targeted therapies in small cell lung cancer (Review)

Oncology Letters, Vol. 5, Iss. 1, 2013-01 ,pp. : 3-11

Spandidos Publications

Access to resources Recommend Favorite

Triple-negative breast cancer: molecular characterization and targeted therapies

By Nicholson Allen Bishop Jennifer Lannin Donald Killelea Brigid Guo Xiaojia Cha Charles Dixon J Michael

Breast Cancer Management, Vol. 2, Iss. 5, 2013-09 ,pp. : 417-430

Future Medicine

Access to resources Recommend Favorite

Endocrine resistance in breast cancer: molecular pathways and rational development of targeted therapies

By Roop Ryan P Ma Cynthia X

Future Oncology, Vol. 8, Iss. 3, 2012-03 ,pp. : 273-292

Future Medicine

Access to resources Recommend Favorite